Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 129,085 | -72,240 | -80,330 | 62,971 | -103,023 |
| Depreciation Amortization | 18,259 | 4,083 | 843 | 3,619 | 15,594 |
| Accounts receivable | -38,288 | -29,437 | 11,613 | -6,453 | 16,730 |
| Other Working Capital | -107,853 | -54,535 | -5,698 | 36,750 | 8,005 |
| Other Operating Activity | 54,251 | 66,706 | 24,072 | 37,166 | 12,311 |
| Operating Cash Flow | $55,454 | $-85,423 | $-49,500 | $134,053 | $-50,383 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 79,782 | -1,509 | 7,156 | -162,382 | -73,629 |
| PPE Investments | -1,428 | -4,040 | -4,663 | -1,350 | -3,137 |
| Investing Cash Flow | $78,354 | $-5,549 | $2,493 | $-163,732 | $-76,766 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 447,350 | 0 | N/A | 203,006 |
| Debt Repayment | -19,560 | -108,082 | -77,516 | -15,995 | -54,250 |
| Common Stock Issued | 63,393 | 14,224 | 13,719 | 147,650 | 1,865 |
| Common Stock Repurchased | -150,117 | -199,998 | 0 | N/A | N/A |
| Other Financing Activity | 0 | -279 | 0 | 0 | 0 |
| Financing Cash Flow | $-106,284 | $153,215 | $-63,797 | $131,655 | $150,621 |
| Beginning Cash Position | 120,679 | 58,436 | 169,240 | 67,264 | 43,792 |
| End Cash Position | 148,203 | 120,679 | 58,436 | 169,240 | 67,264 |
| Net Cash Flow | $27,524 | $62,243 | $-110,804 | $101,976 | $23,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,454 | -85,423 | -49,500 | 134,053 | -50,383 |
| Capital Expenditure | -2,504 | -4,040 | -4,663 | -1,350 | -3,137 |
| Free Cash Flow | 52,950 | -89,463 | -54,163 | 132,703 | -53,520 |